Safety and efficacy in pediatric populations have not been established
SMH recognized for supporting military employees, wins dual ESGR Seven Seals Awards Howell urged caution
The journey is unique for everyone, and a specialist can help you understand if this treatment aligns with your body, your health history, and your goals
This loading dose primes your body for the medication while producing minimal side effects
Until comprehensive Phase 3 safety data are available and reviewed by regulators such as the MHRA, the full safety profile of retatrutide in diverse patient populations remains incompletely characterised
Options include slowing dose escalation, temporarily pausing the medication while we treat your eyes, or switching to alternative diabetes therapies